Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityNo recent work listed

Cheng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4823-1484; OpenAlex author ID A5100737788, A5110684827. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2019: 1 paper · 2020: 3 papers · 2021: 3 papers

Papers 7

  1. MK8722, an AMPK activator, inhibiting carcinoma proliferation, invasion and migration in human pancreatic cancer cells. Co-author DOI 10.1016/j.biopha.2021.112325↗
  2. Correction to: Chemopreventive effect of Betulinic acid via mTOR -Caspases/Bcl2/Bax apoptotic signaling in pancreatic cancer. Co-author DOI 10.1186/s12906-021-03254-w↗
  3. Transcriptome and proteome analysis of the antitumor activity of maslinic acid against pancreatic cancer cells. Co-author DOI 10.18632/aging.203623↗
  4. Chemopreventive effect of Betulinic acid via mTOR -Caspases/Bcl2/Bax apoptotic signaling in pancreatic cancer. Co-author DOI 10.1186/s12906-020-02976-7↗
  5. KRT17 Functions as a Tumor Promoter and Regulates Proliferation, Migration and Invasion in Pancreatic Cancer via mTOR/S6k1 Pathway. Co-author DOI 10.2147/cmar.s243129↗
  6. CC-223, NSC781406, and BGT226 Exerts a Cytotoxic Effect Against Pancreatic Cancer Cells via mTOR Signaling. Co-author DOI 10.3389/fphar.2020.580407↗
  7. Baohuoside I Inhibits the Proliferation of Pancreatic Cancer Cells via mTOR/S6K1-Caspases/Bcl2/Bax Apoptotic Signaling. Co-author DOI 10.2147/cmar.s228926↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Linxiao Sun · 7 shared papers, 2019–2021 · strength 0.99
  2. Hengyue Zhu · 3 shared papers, 2020–2021 · strength 0.45
  3. Yangyang Guo · 3 shared papers, 2020–2021 · strength 0.45
  4. Hewei Zhang · 3 shared papers, 2019–2021 · strength 0.41
  5. Chenlei Zheng · 2 shared papers, 2019–2020 · strength 0.21
  6. Bicheng Chen · 2 shared papers, 2019–2020 · strength 0.21
  7. Wujun Geng · 1 shared paper, 2021 · strength 0.15
  8. Ding Li · 1 shared paper, 2020 · strength 0.11
  9. Fubiao Ni · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.